Pay in 4 interest-free payments of $5.83 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
It found that ingredient declarations varied significantly from one sample to another and were misleading
Both companies posted record revenues in 2024: Novo Nordisk DKK 290.4 billion (~USD 41 billion, +26%) and Eli Lilly USD 45.0 billion (+32%), with Lilly guiding for USD 5861 billion in 2025
The Tirzepatide segment is expected to grow at the fastest CAGR in the coming years, driven by a dual GIP and GLP-1 receptor mechanism providing better results for weight loss
BW reduction 3% was achieved by 39%, 50% and 80% in the placebo, the 4 mg and the 6 mg arm, respectively
US$ 21.92
US$ 22.55
US$ 24.11
US$ 29.23
